Year 2019 / Volume 111 / Number 8
Original
Survival, morbidity and mortality of pancreatic adenocarcinoma after pancreaticoduodenectomy with a total mesopancreas excision

609-614

DOI: 10.17235/reed.2019.6139/2018

Pablo Sánchez Acedo, Javier Herrera Cabezón, Cruz Zazpe Ripa, Antonio Tarifa Castilla,

Abstract
Introduction: pancreatic adenocarcinoma is the most common malignancy in the periampullary region, with a five-year survival rate around 20%. Objective: the goal of our study was to determine the survival and safety data of a number of patients that underwent a cephalic duodenopancreatectomy (CDP) with total mesopancreas excision (TMPE). Material and methods: a prospective observational study was performed of 114 patients with pancreatic adenocarcinoma who underwent duodenopancreatectomy and TMPE over the period 2008-2017. Demographic variables, tumor stage, number of lymph nodes excised, lymph node ratio, R classification, the prognostic factor disease-free interval and survival were all assessed in a multivariate analysis. Results: complications were reported for 54 (47.3%) patients, of which 22 (19.3%) were categorized as serious. The mortality rate was 4.3% and the mean follow-up was 26.2 months. During this period, 73 (64%) patients relapsed after a mean interval of 40.9 months. The relapse pattern was mainly hepatic (26.3%), followed by local relapse (20%). Mean survival was 40.38 and actuarial survival was 26.6% at five years. Relapse-related factors included stage T3 or higher (RR 8.1 [1.1-61]) and an R1 resection (RR 13.4 [2.7-66.5]) and survival-related factors included an R1 resection (RR 10.7 [2.5-46.2]). Conclusion: TMPE ensures an adequate lymphadenectomy and lymph node ratio according to reported standards. The survival of patients that have undergone surgery for pancreatic adenocarcinoma in our institution is 68.4% at one year and 26.6% at five years. An R1 resection is the primary factor for both relapse and survival.
New comment
Comments

12/01/2025 8:59:47
7

21/10/2019 6:36:57
Soy cirujano oncológo y me parece interesante ver las tasas de sobrevida en pacientes con cáncer de pancreas cuando se emplea la ETMP

References
1. Hidalgo M, Cascinu S, Kleeff J, et al. Addressing the challenges of pancreatic cancer: Future directions for improving outcomes. Pancreatol Off J Int Assoc Pancreatol . [et al]. 2015;15(1):8-18. doi:10.1016/j.pan.2014.10.001.
DOI: 10.1016/j.pan.2014.10.001
2. Sabater L, Calvete J, Aparisi L, et al. [Pancreatic and periampullary tumors: morbidity, mortality, functional results and long-term survival]. Cirugía Española. 2009;86(3):159-166. doi:10.1016/j.ciresp.2009.03.014.
DOI: 10.1016/j.ciresp.2009.03.014
3. Saif MW. Advancements in the management of pancreatic cancer: 2013. JOP J pancreas. 2013;14(2):112-118. http://www.ncbi.nlm.nih.gov/pubmed/23474549.
4. Gockel I, Domeyer M, Wolloscheck T, Konerding MA, Junginger T. Resection of the mesopancreas (RMP): a new surgical classification of a known anatomical space. World J Surg Oncol. 2007;5:44. doi:10.1186/1477-7819-5-44.
DOI: 10.1186/1477-7819-5-44
5. Pessaux P, Regenet N, Arnaud JP. [Resection of the retroportal pancreatic lamina during a cephalic pancreaticoduodenectomy: first dissection of the superior mesenteric artery]. Ann Chir. 2003;128(9):633-636.
DOI: 10.1016/j.anchir.2003.10.010
6. Pessaux P, Varma D, Arnaud J-P. Pancreaticoduodenectomy: superior mesenteric artery first approach. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2006;10(4):607-611. doi:10.1016/j.gassur.2005.05.001.
DOI: 10.1016/j.gassur.2005.05.001
7. Figueras J, Codina-Barreras A, López-Ben S, et al. [Cephalic duodenopancreatectomy in periampullary tumours. Dissection of the superior mesenteric artery as aninitial approach. Description of the technique and an assessment of our initial experience]. Cirugía española. 2008;83(4):186-193. http://www.ncbi.nlm.nih.gov/pubmed/18358178.
8. Sanjay P, Takaori K, Govil S, Shrikhande S V., Windsor JA. “Artery-first” approaches to pancreatoduodenectomy. Br J Surg. 2012;99(8):1027-1035. doi:10.1002/bjs.8763.
DOI: 10.1002/bjs.8763
9. Adham M, Singhirunnusorn J. Surgical technique and results of total mesopancreas excision (TMpE) in pancreatic tumors. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2012;38(4):340-345. doi:10.1016/j.ejso.2011.12.015.
DOI: 10.1016/j.ejso.2011.12.015
10. Ramia JM, De-la-Plaza R, Manuel-Vazquez A, Lopez-Marcano A, Morales R. Systematic review of the mesopancreas: concept and clinical implications. Clin Transl Oncol. 2018;20(11):1385-1391. doi:10.1007/s12094-018-1869-5.
DOI: 10.1007/s12094-018-1869-5
11. Bockhorn M, Uzunoglu FG, Adham M, et al. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2014;155(6):977-988. doi:10.1016/j.surg.2014.02.001.
DOI: 10.1016/j.surg.2014.02.001
12. Tol JAMG, Gouma DJ, Bassi C, et al. Definition of a standard lymphadenectomy in surgery for pancreatic ductal adenocarcinoma: a consensus statement by the International Study Group on Pancreatic Surgery (ISGPS). Surgery. 2014;156(3):591-600. doi:10.1016/j.surg.2014.06.016.
DOI: 10.1016/j.surg.2014.06.016
13. Gockel I, Domeyer M, Wolloscheck T, Konerding MA, Junginger T. Resection of the mesopancreas (RMP): a new surgical classification of a known anatomical space. World J Surg Oncol. 2007;5:44. doi:10.1186/1477-7819-5-44.
DOI: 10.1186/1477-7819-5-44
14. Shrikhande S V., Sivasanker M, Vollmer CM, et al. Pancreatic anastomosis after pancreatoduodenectomy: A position statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. December 2016. doi:10.1016/j.surg.2016.11.021.
DOI: 10.1016/j.surg.2016.11.021
15. Delcore R, Thomas JH, Pierce GE, Hermreck AS. Pancreatogastrostomy: a safe drainage procedure after pancreatoduodenectomy. Surgery. 1990;108(4):641-645; discussion 645-647. http://www.ncbi.nlm.nih.gov/pubmed/2218874.
16. Herrera-Cabezón FJ, Sánchez-Acedo P, Zazpe-Ripa C, Tarifa-Castilla A, Lera-Tricas JM. Quality standards in 480 pancreatic resections: a prospective observational study. Rev Esp Enferm Dig. 2015;107(3):143-151. http://www.ncbi.nlm.nih.gov/pubmed/25733038. Accessed December 15, 2017.
17. Haljamäe H. Anesthetic risk factors. Acta Chir Scand Suppl. 1989;550:11-9; discussion 19-21. http://www.ncbi.nlm.nih.gov/pubmed/2652961. Accessed July 13, 2018.
18. Dindo D, Demartines N, Clavien P-A. Classification of Surgical Complications. Ann Surg. 2004;240(2):205-213. doi:10.1097/01.sla.0000133083.54934.ae.
DOI: 10.1097/01.sla.0000133083.54934.ae
19. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138(1):8-13. doi:10.1016/j.surg.2005.05.001.
DOI: 10.1016/j.surg.2005.05.001
20. Wente MN, Bassi C, Dervenis C, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2007;142(5):761-768. doi:10.1016/j.surg.2007.05.005.
DOI: 10.1016/j.surg.2007.05.005
21. Welsch T, Eisele H, Zschäbitz S, Hinz U, Büchler MW, Wente MN. Critical appraisal of the International Study Group of Pancreatic Surgery (ISGPS) consensus definition of postoperative hemorrhage after pancreatoduodenectomy. Langenbecks Arch Surg. 2011;396(6):783-791. doi:10.1007/s00423-011-0811-x.
DOI: 10.1007/s00423-011-0811-x
22. Lüttges J. [What’s new? The 2010 WHO classification for tumours of the pancreas]. Pathologe. 2011;32 Suppl 2:332-336. doi:10.1007/s00292-011-1515-2.
DOI: 10.1007/s00292-011-1515-2
23. Pawlik TM, Gleisner AL, Cameron JL, et al. Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer. Surgery. 2007;141(5):610-618. doi:10.1016/j.surg.2006.12.013.
DOI: 10.1016/j.surg.2006.12.013
24. Shukla PJ, Barreto SG, Fingerhut A, et al. Toward improving uniformity and standardization in the reporting of pancreatic anastomoses: a new classification system by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 2010;147(1):144-153. doi:10.1016/j.surg.2009.09.003.
DOI: 10.1016/j.surg.2009.09.003
25. Sabater L, Mora I, Gámez del Castillo JM, et al. Estándares de calidad en la cirugía oncológica pancreática en España. Cirugía Española. 2018;96(6):342-351. doi:10.1016/j.ciresp.2018.03.002.
DOI: 10.1016/j.ciresp.2018.03.002
26. Katz MHG, Wang H, Fleming JB, et al. Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma. Ann Surg Oncol. 2009;16(4):836-847. doi:10.1245/s10434-008-0295-2.
DOI: 10.1245/s10434-008-0295-2
27. Huebner M, Kendrick M, Reid-Lombardo KM, et al. Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2012;16(5):920-926. doi:10.1007/s11605-012-1853-2.
DOI: 10.1007/s11605-012-1853-2
28. Tomlinson JS, Jain S, Bentrem DJ, et al. Accuracy of Staging Node-Negative Pancreas Cancer. Arch Surg. 2007;142(8):767. doi:10.1001/archsurg.142.8.767.
DOI: 10.1001/archsurg.142.8.767
29. Riediger H, Keck T, Wellner U, et al. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2009;13(7):1337-1344. doi:10.1007/s11605-009-0919-2.
DOI: 10.1007/s11605-009-0919-2
30. Showalter TN, Winter KA, Berger AC, et al. The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704. Int J Radiat Oncol Biol Phys. 2011;81(5):1328-1335. doi:10.1016/j.ijrobp.2010.07.1993.
DOI: 10.1016/j.ijrobp.2010.07.1993
31. Dusch N, Weiss C, Ströbel P, Kienle P, Post S, Niedergethmann M. Factors predicting long-term survival following pancreatic resection for ductal adenocarcinoma of the pancreas: 40 years of experience. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2014;18(4):674-681. doi:10.1007/s11605-013-2408-x.
DOI: 10.1007/s11605-013-2408-x
32. Sun J, Yang Y, Wang X, et al. Meta-analysis of the efficacies of extended and standard pancreatoduodenectomy for ductal adenocarcinoma of the head of the pancreas. World J Surg. 2014;38(10):2708-2715. doi:10.1007/s00268-014-2633-9.
DOI: 10.1007/s00268-014-2633-9
33. Ke K, Chen W, Chen Y. Standard and extended lymphadenectomy for adenocarcinoma of the pancreatic head: a meta-analysis and systematic review. J Gastroenterol Hepatol. 2014;29(3):453-462. doi:10.1111/jgh.12393.
DOI: 10.1111/jgh.12393
34. Hishinuma S, Ogata Y, Tomikawa M, Ozawa I, Hirabayashi K, Igarashi S. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg Off J Soc Surg Aliment Tract. 2006;10(4):511-518. doi:10.1016/j.gassur.2005.09.016.
DOI: 10.1016/j.gassur.2005.09.016
35. Sugiura T, Uesaka K, Mihara K, et al. Margin status, recurrence pattern, and prognosis after resection of pancreatic cancer. Surgery. 2013;154(5):1078-1086. doi:10.1016/j.surg.2013.04.015.
DOI: 10.1016/j.surg.2013.04.015
36. Kawabata Y, Tanaka T, Nishi T, Monma H, Yano S, Tajima Y. Appraisal of a total meso-pancreatoduodenum excision with pancreaticoduodenectomy for pancreatic head carcinoma. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2012;38(7):574-579. doi:10.1016/j.ejso.2012.04.007.
DOI: 10.1016/j.ejso.2012.04.007
37. Kawabata Y, Nishi T, Tanaka T, Tajima Y. Safety and Feasibility of a Pancreaticoduodenectomy with Total Meso-Pancreatoduodenum Excision: Analysis in Various Periampullary Disorders. Hepatogastroenterology. 2014;61(131):821-827. http://www.ncbi.nlm.nih.gov/pubmed/26176080. Accessed November 20, 2018.
38. Wu W, Wang X, Wu X, et al. Total mesopancreas excision for pancreatic head cancer: analysis of 120 cases. Chin J Cancer Res. 2016;28(4):423-428. doi:10.21147/j.issn.1000-9604.2016.04.05.
DOI: 10.21147/j.issn.1000-9604.2016.04.05
39. Mirkin KA, Hollenbeak CS, Wong J. Greater lymph node retrieval and lymph node ratio impacts survival in resected pancreatic cancer. J Surg Res. 2017;220:12-24. doi:10.1016/j.jss.2017.06.076.
DOI: 10.1016/j.jss.2017.06.076
40. Tempero MA, Malafa MP, Behrman SW, et al. Pancreatic adenocarcinoma, version 2.2014: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2014;12(8):1083-1093. http://www.ncbi.nlm.nih.gov/pubmed/25099441. Accessed November 20, 2018.
41. Slidell MB, Chang DC, Cameron JL, et al. Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis. Ann Surg Oncol. 2008;15(1):165-174. doi:10.1245/s10434-007-9587-1.
DOI: 10.1245/s10434-007-9587-1
42. Vuarnesson H, Lupinacci RM, Semoun O, et al. Number of examined lymph nodes and nodal status assessment in pancreaticoduodenectomy for pancreatic adenocarcinoma. Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol. 2013;39(10):1116-1121. doi:10.1016/j.ejso.2013.07.089.
DOI: 10.1016/j.ejso.2013.07.089
43. Tol J a. MG, Brosens L a. A, van Dieren S, et al. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer. Br J Surg. 2015;102(3):237-245. doi:10.1002/bjs.9709.
DOI: 10.1002/bjs.9709
Adham, M., and J. Singhirunnusorn. 2012. “Surgical Technique and Results of Total Mesopancreas Excision (TMpE) in Pancreatic Tumors.” European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 38 (4): 340–45. https://doi.org/10.1016/j.ejso.2011.12.015.
Bassi, Claudio, Christos Dervenis, Giovanni Butturini, Abe Fingerhut, Charles Yeo, Jakob Izbicki, John Neoptolemos, et al. 2005. “Postoperative Pancreatic Fistula: An International Study Group (ISGPF) Definition.” Surgery 138 (1): 8–13. https://doi.org/10.1016/j.surg.2005.05.001.
Bockhorn, Maximilian, Faik G. Uzunoglu, Mustapha Adham, Clem Imrie, Miroslav Milicevic, Aken A. Sandberg, Horacio J. Asbun, et al. 2014. “Borderline Resectable Pancreatic Cancer: A Consensus Statement by the International Study Group of Pancreatic Surgery (ISGPS).” Surgery 155 (6): 977–88. https://doi.org/10.1016/j.surg.2014.02.001.
Delcore, R., J. H. Thomas, G. E. Pierce, and A. S. Hermreck. 1990. “Pancreatogastrostomy: A Safe Drainage Procedure after Pancreatoduodenectomy.” Surgery 108 (4): 641-645; discussion 645-647. http://www.ncbi.nlm.nih.gov/pubmed/2218874.
Dindo, Daniel, Nicolas Demartines, and Pierre-Alain Clavien. 2004. “Classification of Surgical Complications.” Annals of Surgery 240 (2): 205–13. https://doi.org/10.1097/01.sla.0000133083.54934.ae.
Dusch, Niloufar, Christel Weiss, Philip Ströbel, Peter Kienle, Stefan Post, and Marco Niedergethmann. 2014. “Factors Predicting Long-Term Survival Following Pancreatic Resection for Ductal Adenocarcinoma of the Pancreas: 40 Years of Experience.” Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 18 (4): 674–81. https://doi.org/10.1007/s11605-013-2408-x.
Figueras, Joan, Antonio Codina-Barreras, Santiago López-Ben, Albert Maroto, Silvia Torres-Bahí, Héctor Daniel González, Maite Albiol, et al. 2008. “[Cephalic duodenopancreatectomy in periampullary tumours. Dissection of the superior mesenteric artery as aninitial approach. Description of the technique and an assessment of our initial experience].” Cirugía española 83 (4): 186–93. http://www.ncbi.nlm.nih.gov/pubmed/18358178.
Gockel, Ines, Mario Domeyer, Tanja Wolloscheck, Moritz A. Konerding, and Theodor Junginger. 2007a. “Resection of the Mesopancreas (RMP): A New Surgical Classification of a Known Anatomical Space.” World Journal of Surgical Oncology 5: 44. https://doi.org/10.1186/1477-7819-5-44.
Gockel, Ines, Mario Domeyer, Tanja Wolloscheck, Moritz A Konerding, and Theodor Junginger. 2007b. “Resection of the Mesopancreas (RMP): A New Surgical Classification of a Known Anatomical Space.” World Journal of Surgical Oncology 5: 44. https://doi.org/10.1186/1477-7819-5-44.
Haljamäe, H. 1989. “Anesthetic Risk Factors.” Acta Chirurgica Scandinavica. Supplementum 550: 11-9; discussion 19-21. http://www.ncbi.nlm.nih.gov/pubmed/2652961.
Herrera-Cabezón, Francisco Javier, Pablo Sánchez-Acedo, Cruz Zazpe-Ripa, Antonio Tarifa-Castilla, and José Miguel Lera-Tricas. 2015. “Quality Standards in 480 Pancreatic Resections: A Prospective Observational Study.” Revista Espanola de Enfermedades Digestivas : Organo Oficial de La Sociedad Espanola de Patologia Digestiva 107 (3): 143–51. http://www.ncbi.nlm.nih.gov/pubmed/25733038.
Hidalgo, Manuel, Stefano Cascinu, Jörg Kleeff, Roberto Labianca, J.-Matthias Löhr, John Neoptolemos, Francisco X. Real, Jean-Luc Van Laethem, and Volker Heinemann. 2015. “Addressing the Challenges of Pancreatic Cancer: Future Directions for Improving Outcomes.” Pancreatology: Official Journal of the International Association of Pancreatology (IAP) ... [et Al.] 15 (1): 8–18. https://doi.org/10.1016/j.pan.2014.10.001.
Hishinuma, Shoichi, Yoshiro Ogata, Moriaki Tomikawa, Iwao Ozawa, Kaoru Hirabayashi, and Seiji Igarashi. 2006. “Patterns of Recurrence after Curative Resection of Pancreatic Cancer, Based on Autopsy Findings.” Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 10 (4): 511–18. https://doi.org/10.1016/j.gassur.2005.09.016.
Huebner, Marianne, Michael Kendrick, Kaye M Reid-Lombardo, Florencia Que, Terry Therneau, Rui Qin, John Donohue, David Nagorney, Michael Farnell, and Michael Sarr. 2012. “Number of Lymph Nodes Evaluated: Prognostic Value in Pancreatic Adenocarcinoma.” Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 16 (5): 920–26. https://doi.org/10.1007/s11605-012-1853-2.
Katz, Matthew H G, Huamin Wang, Jason B Fleming, Charlotte C Sun, Rosa F Hwang, Robert A Wolff, Gauri Varadhachary, et al. 2009. “Long-Term Survival after Multidisciplinary Management of Resected Pancreatic Adenocarcinoma.” Annals of Surgical Oncology 16 (4): 836–47. https://doi.org/10.1245/s10434-008-0295-2.
Kawabata, Y., T. Tanaka, T. Nishi, H. Monma, S. Yano, and Y. Tajima. 2012. “Appraisal of a Total Meso-Pancreatoduodenum Excision with Pancreaticoduodenectomy for Pancreatic Head Carcinoma.” European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 38 (7): 574–79. https://doi.org/10.1016/j.ejso.2012.04.007.
Kawabata, Y, T Nishi, T Tanaka, and Y Tajima. 2014. “Safety and Feasibility of a Pancreaticoduodenectomy with Total Meso-Pancreatoduodenum Excision: Analysis in Various Periampullary Disorders.” Hepato-Gastroenterology 61 (131): 821–27. http://www.ncbi.nlm.nih.gov/pubmed/26176080.
Ke, Kun, Wen Chen, and Yanling Chen. 2014. “Standard and Extended Lymphadenectomy for Adenocarcinoma of the Pancreatic Head: A Meta-Analysis and Systematic Review.” Journal of Gastroenterology and Hepatology 29 (3): 453–62. https://doi.org/10.1111/jgh.12393.
Lüttges, J. 2011. “[What’s new? The 2010 WHO classification for tumours of the pancreas].” Der Pathologe 32 Suppl 2 (November): 332–36. https://doi.org/10.1007/s00292-011-1515-2.
Mirkin, Katelin A, Christopher S Hollenbeak, and Joyce Wong. 2017. “Greater Lymph Node Retrieval and Lymph Node Ratio Impacts Survival in Resected Pancreatic Cancer.” The Journal of Surgical Research 220 (December): 12–24. https://doi.org/10.1016/j.jss.2017.06.076.
Pawlik, Timothy M., Ana L. Gleisner, John L. Cameron, Jordan M. Winter, Lia Assumpcao, Keith D. Lillemoe, Christopher Wolfgang, et al. 2007. “Prognostic Relevance of Lymph Node Ratio Following Pancreaticoduodenectomy for Pancreatic Cancer.” Surgery 141 (5): 610–18. https://doi.org/10.1016/j.surg.2006.12.013.
Pessaux, P, N Regenet, and J P Arnaud. 2003. “[Resection of the retroportal pancreatic lamina during a cephalic pancreaticoduodenectomy: first dissection of the superior mesenteric artery].” Annales de chirurgie 128 (9): 633–36.
DOI: 10.1016/j.anchir.2003.10.010
Pessaux, Patrick, Deepak Varma, and Jean-Pierre Arnaud. 2006. “Pancreaticoduodenectomy: Superior Mesenteric Artery First Approach.” Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 10 (4): 607–11. https://doi.org/10.1016/j.gassur.2005.05.001.
Ramia, J M, R De-la-Plaza, A Manuel-Vazquez, A Lopez-Marcano, and R Morales. 2018. “Systematic Review of the Mesopancreas: Concept and Clinical Implications.” Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20 (11): 1385–91. https://doi.org/10.1007/s12094-018-1869-5.
Riediger, Hartwig, Tobias Keck, Ulrich Wellner, Axel zur Hausen, Ulrich Adam, Ulrich T Hopt, and Frank Makowiec. 2009. “The Lymph Node Ratio Is the Strongest Prognostic Factor after Resection of Pancreatic Cancer.” Journal of Gastrointestinal Surgery: Official Journal of the Society for Surgery of the Alimentary Tract 13 (7): 1337–44. https://doi.org/10.1007/s11605-009-0919-2.
Sabater, Luis, Julio Calvete, Luis Aparisi, Raul Cánovas, Elena Muñoz, Ramón Añón, Susana Roselló, et al. 2009. “[Pancreatic and periampullary tumors: morbidity, mortality, functional results and long-term survival].” Cirugía Española 86 (3): 159–66. https://doi.org/10.1016/j.ciresp.2009.03.014.
Sabater, Luis, Isabel Mora, Juan Manuel Gámez del Castillo, Javier Escrig-Sos, Elena Muñoz-Forner, Marina Garcés-Albir, Dimitri Dorcaratto, and Joaquín Ortega. 2018. “Estándares de Calidad En La Cirugía Oncológica Pancreática En España.” Cirugía Española 96 (6): 342–51. https://doi.org/10.1016/j.ciresp.2018.03.002.
Saif, Muhammad Wasif. 2013. “Advancements in the Management of Pancreatic Cancer: 2013.” JOP: Journal of the Pancreas 14 (2): 112–18. http://www.ncbi.nlm.nih.gov/pubmed/23474549.
Sanjay, P., K. Takaori, S. Govil, S. V. Shrikhande, and J. A. Windsor. 2012. “‘Artery-First’ Approaches to Pancreatoduodenectomy.” The British Journal of Surgery 99 (8): 1027–35. https://doi.org/10.1002/bjs.8763.
Showalter, Timothy N, Kathryn A Winter, Adam C Berger, William F Regine, Ross A Abrams, Howard Safran, John P Hoffman, Al B Benson, John S MacDonald, and Christopher G Willett. 2011. “The Influence of Total Nodes Examined, Number of Positive Nodes, and Lymph Node Ratio on Survival after Surgical Resection and Adjuvant Chemoradiation for Pancreatic Cancer: A Secondary Analysis of RTOG 9704.” International Journal of Radiation Oncology, Biology, Physics 81 (5): 1328–35. https://doi.org/10.1016/j.ijrobp.2010.07.1993.
Shrikhande, Shailesh V., Masillamany Sivasanker, Charles M. Vollmer, Helmut Friess, Marc G. Besselink, Abe Fingerhut, Charles J. Yeo, et al. 2016. “Pancreatic Anastomosis after Pancreatoduodenectomy: A Position Statement by the International Study Group of Pancreatic Surgery (ISGPS).” Surgery, December. https://doi.org/10.1016/j.surg.2016.11.021.
Slidell, Mark B., David C. Chang, John L. Cameron, Christopher Wolfgang, Joseph M. Herman, Richard D. Schulick, Michael A. Choti, and Timothy M. Pawlik. 2008. “Impact of Total Lymph Node Count and Lymph Node Ratio on Staging and Survival after Pancreatectomy for Pancreatic Adenocarcinoma: A Large, Population-Based Analysis.” Annals of Surgical Oncology 15 (1): 165–74. https://doi.org/10.1245/s10434-007-9587-1.
Sugiura, Teiichi, Katsuhiko Uesaka, Kisho Mihara, Keiko Sasaki, Hideyuki Kanemoto, Takashi Mizuno, and Yukiyasu Okamura. 2013. “Margin Status, Recurrence Pattern, and Prognosis after Resection of Pancreatic Cancer.” Surgery 154 (5): 1078–86. https://doi.org/10.1016/j.surg.2013.04.015.
Sun, Jingfeng, Yinxue Yang, Xuan Wang, Zhen Yu, Ting Zhang, Jun Song, Hewei Zhao, et al. 2014. “Meta-Analysis of the Efficacies of Extended and Standard Pancreatoduodenectomy for Ductal Adenocarcinoma of the Head of the Pancreas.” World Journal of Surgery 38 (10): 2708–15. https://doi.org/10.1007/s00268-014-2633-9.
Tempero, Margaret A, Mokenge P Malafa, Stephen W Behrman, Al B Benson, Ephraim S Casper, E Gabriela Chiorean, Vincent Chung, et al. 2014. “Pancreatic Adenocarcinoma, Version 2.2014: Featured Updates to the NCCN Guidelines.” Journal of the National Comprehensive Cancer Network : JNCCN 12 (8): 1083–93. http://www.ncbi.nlm.nih.gov/pubmed/25099441.
Tol, J. a. M. G., L. a. A. Brosens, S. van Dieren, T. M. van Gulik, O. R. C. Busch, M. G. H. Besselink, and D. J. Gouma. 2015. “Impact of Lymph Node Ratio on Survival in Patients with Pancreatic and Periampullary Cancer.” The British Journal of Surgery 102 (3): 237–45. https://doi.org/10.1002/bjs.9709.
Tol, Johanna A. M. G., Dirk J. Gouma, Claudio Bassi, Christos Dervenis, Marco Montorsi, Mustapha Adham, Ake Andrén-Sandberg, et al. 2014. “Definition of a Standard Lymphadenectomy in Surgery for Pancreatic Ductal Adenocarcinoma: A Consensus Statement by the International Study Group on Pancreatic Surgery (ISGPS).” Surgery 156 (3): 591–600. https://doi.org/10.1016/j.surg.2014.06.016.
Tomlinson, James S., Sushma Jain, David J Bentrem, Evangelos G Sekeris, Melinda A Maggard, O Joe Hines, Howard A Reber, and Clifford Y Ko. 2007. “Accuracy of Staging Node-Negative Pancreas Cancer.” Archives of Surgery 142 (8): 767. https://doi.org/10.1001/archsurg.142.8.767.
Verbeke, C. S., D. Leitch, K. V. Menon, M. J. McMahon, P. J. Guillou, and A. Anthoney. 2006. “Redefining the R1 Resection in Pancreatic Cancer.” British Journal of Surgery 93 (10): 1232–37. https://doi.org/10.1002/bjs.5397.
Vuarnesson, H, R M Lupinacci, O Semoun, M Svrcek, C Julié, P Balladur, C Penna, J B Bachet, M Resche-Rigon, and F Paye. 2013. “Number of Examined Lymph Nodes and Nodal Status Assessment in Pancreaticoduodenectomy for Pancreatic Adenocarcinoma.” European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 39 (10): 1116–21. https://doi.org/10.1016/j.ejso.2013.07.089.
Welsch, Thilo, Hanna Eisele, Stefanie Zschäbitz, Ulf Hinz, Markus W Büchler, and Moritz N Wente. 2011. “Critical Appraisal of the International Study Group of Pancreatic Surgery (ISGPS) Consensus Definition of Postoperative Hemorrhage after Pancreatoduodenectomy.” Langenbeck’s Archives of Surgery / Deutsche Gesellschaft Für Chirurgie 396 (6): 783–91. https://doi.org/10.1007/s00423-011-0811-x.
Wente, Moritz N, Claudio Bassi, Christos Dervenis, Abe Fingerhut, Dirk J Gouma, Jakob R Izbicki, John P Neoptolemos, et al. 2007. “Delayed Gastric Emptying (DGE) after Pancreatic Surgery: A Suggested Definition by the International Study Group of Pancreatic Surgery (ISGPS).” Surgery 142 (5): 761–68. https://doi.org/10.1016/j.surg.2007.05.005.
Wu, Wenguang, Xu’an Wang, Xiangsong Wu, Maolan Li, Hao Weng, Yang Cao, Ruifa Bao, et al. 2016. “Total Mesopancreas Excision for Pancreatic Head Cancer: Analysis of 120 Cases.” Chinese Journal of Cancer Research = Chung-Kuo Yen C
Related articles

Original

Complications and survival following percutaneous endoscopic gastrostomy tube placement

DOI: 10.17235/reed.2024.10335/2024

Original

Prognostic value of neutrophil-to-lymphocyte ratio at diagnosis in colorectal cancer: propensity score analysis

DOI: 10.17235/reed.2024.10041/2023

Editorial

Liver transplantation in colorectal metastases. Is there an indication for this procedure?

DOI: 10.17235/reed.2023.9873/2023

Letter

Upper digestive bleeding secondary to duodenal infiltration due to pancreatic cancer: a therapeutic challenge

DOI: 10.17235/reed.2023.9738/2023

Letter

Pilot study: a detailed analysis of the timing of immuno-inflammatory indices in gastric cancer, and their assessment together with TNM as supplementary prognostic factors

DOI: 10.17235/reed.2023.9548/2023

Original

Metabolic syndrome before liver transplantation: does it have an impact on post liver transplantation outcome?

DOI: 10.17235/reed.2022.8384/2021

Letter

Risk factors for mortality in patients with acute bacterial cholangitis — Type-2 diabetes is a significant clinical predictor

DOI: 10.17235/reed.2021.8251/2021

Letter

Duodenal lymphangiectasias — The first sign of pancreatic adenocarcinoma

DOI: 10.17235/reed.2021.7823/2021

Original

Characteristics and outcome of incidental hepatocellular carcinoma after liver transplantation: a cohort study

DOI: 10.17235/reed.2021.7744/2020

Original

Low applicability of the ‘‘Six-and-twelve score” in hepatocellular carcinoma treated with Drug-Eluting Beads Transarterial Chemoembolization.

DOI: 10.17235/reed.2021.7696/2020

Original

Biosimilar infliximab CPT-13 for inflammatory bowel disease in a real clinical setting: pharmacokinetic outcomes, immunogenicity, and drug survival

DOI: 10.17235/reed.2021.7638/2020

Original

Impact of interval timing to surgery on tumor response after neoadjuvant treatment for gastric cancer

DOI: 10.17235/reed.2020.6763/2019

Original

Prognostic significance of lymph node count in high-risk node-negative colon carcinoma

DOI: 10.17235/reed.2020.6709/2019

Original

Long-term follow-up after endoscopic submucosal dissection of colorectal lesions in a Spanish cohort

DOI: 10.17235/reed.2020.6268/2019

Original

Endoscopic submucosal dissection for gastric epithelial lesions: long-term results in a Spanish cohort

DOI: 10.17235/reed.2020.6239/2019

Original

Prognostic value of serum high-density lipoprotein cholesterol in patients with gallbladder cancer

DOI: 10.17235/reed.2019.6201/2019

Original

A teaching project on rectal cancer and concentration of procedures: a comparison of oncological results between Catalonia and the rest of autonomous communities

DOI: 10.17235/reed.2019.5901/2018

Original

Clinicopathologic factors associated with recurrence and long-term survival in node-negative advanced gastric cancer patients

DOI: 10.17235/reed.2018.5829/2018

Editorial

Colorectal cancer screening and survival

DOI: 10.17235/reed.2018.5870/2018

Original

First hospital contact via the Emergency Department is an independent predictor of overall survival and disease-free survival in patients with colorectal cancer

DOI: 10.17235/reed.2019.5777/2018

Original

Colonic stent vs surgical resection of the primary tumor. Effect on survival from stage-IV obstructive colorectal cancer

DOI: 10.17235/reed.2020.5701/2018

Original

Screening-detected colorectal cancers show better long-term survival compared with stage-matched symptomatic cancers

DOI: 10.17235/reed.2018.5509/2018

Original

Graft survival after liver transplantation: an approach to a new Spanish risk index

DOI: 10.17235/reed.2018.5473/2018

Original

Gastrointestinal stromal tumors: 16 years’ experience within a university hospital

DOI: 10.17235/reed.2018.5199/2017

Original

Self-expanding metal stents in postoperative esophageal leaks

DOI: 10.17235/reed.2016.3987/2015

Original

Recurrence of liver metastases from colorectal cancer and repeat liver resection

DOI: 10.17235/reed.2015.3843/2015

Original

Characteristics and pattern of recurrence after curative surgery in oesophageal cancer

DOI: 10.17235/reed.2015.3748/2015

Original

Study of the expression of cathepsins in histological material from pancreatic lesions

DOI: 10.17235/reed.2016.3749/2015

Letter to the Editor

Synchronic gastric and pancreatic ductal adenocarcinoma. A case report

DOI: 10.17235/reed.2015.3720/2014

Citation tools
Sánchez Acedo P, Herrera Cabezón J, Zazpe Ripa C, Tarifa Castilla A. Survival, morbidity and mortality of pancreatic adenocarcinoma after pancreaticoduodenectomy with a total mesopancreas excision. 6139/2018


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 2976 visits.
This article has been downloaded 341 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 22/12/2018

Accepted: 09/02/2019

Online First: 18/07/2019

Published: 31/07/2019

Article revision time: 42 days

Article Online First time: 208 days

Article editing time: 221 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Home
Articles
Current issues
Previous issues
Most read articles
Clinical guidelines
Reviews
Topic collection
Submit a manuscript
Submit a manuscript
Information for authors
Language editing services
Editorial time – Publication time
ORCID guide
PubMed guide
Journal info
About the journal
Editorial board
For reviewers
For advertisers
REED centenary
Open access
Articles in press
REED awards
Home
Articles
Current issues
Previous issues
Most read articles
Clinical guidelines
Reviews
Topic collection
Submit a manuscript
Submit a manuscript
Information for authors
Language editing services
Editorial time – Publication time
ORCID guide
PubMed guide
Journal info
About the journal
Editorial board
For reviewers
For advertisers
REED centenary
Open access
Articles in press
REED awards
Home
Articles
Current issues
Previous issues
Most read articles
Clinical guidelines
Reviews
Topic collection
Submit a manuscript
Submit a manuscript
Information for authors
Language editing services
Editorial time – Publication time
ORCID guide
PubMed guide
Journal info
About the journal
Editorial board
For reviewers
For advertisers
REED centenary
Open access
Articles in press
REED awards
Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2025 y Creative Commons. The Spanish Journal of Gastroenterology